Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma
Clinical trial NCT00072358 · COMPLETED
Trial details
- NCT number
- NCT00072358
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Primary completion
- 2021-01-15
- Enrollment
- 291
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.